Sirexatamab (DKN-01) is a humanized monoclonal antibody targeting DKK1 (dickkopf homolog 1), suitable for studying tumors expressing DKK1, such as advanced esophageal and gastric cancers.
Purity:
95.00%
CAS Number:
[2414962-49-3]
Target:
Wnt/beta-catenin
* VAT and and shipping costs not included. Errors and price changes excepted